Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
557.00    0.00 (0.00%)
Bid:
556.00
Ask:
557.00
Spread: 1.00 (0.18%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Change to Executive Committee

17 Jul 2019 07:02

RNS Number : 7332F
Tate & Lyle PLC
17 July 2019
Β 

Β 

Β 

TATE & LYLE PLC

Β 

17 July 2019

Β 

Tate & Lyle announces departure of President, Food & Beverage Solutions

Β 

Tate & Lyle PLC (Tate & Lyle) announces that Joan Braca, President, Food & Beverage Solutions will be leaving Tate & Lyle on 30 August 2019 to take up a new role as Sector Chief Executive, Clean Air at Johnson Matthey Plc.

Β 

Nick Hampton, Chief Executive Tate & Lyle, said: "I would like to thank Joan for the significant contribution she has made to the growth of our Food & Beverage Solutions business over the last five years, and for developing a strong and talented leadership team beneath her. On behalf of myself and the Board, we wish Joan every success in her new role."

Β 

Β 

For more information contact Tate & Lyle PLC:

Β 

Christopher Marsh, VP Investor Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Β 

Nick Hasell, FTI Consulting (Media)

Tel: +44 (0)20 3727 1234 or Mobile: +44 (0)7825 523 383

Β 

Β 

About Tate & Lyle:Β 

Β 

Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Β 

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Β 

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Β 

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition.

Β 

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2019, Tate & Lyle sales totalled Β£2.8Β billion.

Β 

For more information, please visitΒ http://www.tateandlyle.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCLLFFSDRIRLIA
Date   Source Headline
10th Jul 20263:41 pmRNSForm 8.5 (EPT/RI) - Amendment Tate & Lyle PLC
10th Jul 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
10th Jul 20262:46 pmRNSForm 8.3 - Tate & Lyle plc
10th Jul 20262:43 pmRNSForm 8.3 - Tate & Lyle plc
10th Jul 20262:27 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
10th Jul 20262:19 pmRNSForm 8.3 Tate & Lyle Plc
10th Jul 202612:44 pmRNSForm 8.3 Tate & Lyle plc
10th Jul 202612:31 pmRNSForm 8.3 TATE & LYLE PLC
10th Jul 202612:12 pmRNSForm 8.3 Tate & Lyle Plc
10th Jul 202612:01 pmRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
10th Jul 202611:46 amRNSForm 8.3 - Tate & Lyle plc
10th Jul 202611:39 amRNSForm 8.3 - Tate & Lyle plc
10th Jul 202611:28 amRNSForm 8.3 Tate & Lyle Plc
10th Jul 202611:26 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
10th Jul 202611:14 amRNSForm 8.5 (EPT/RI) - Tate & Lyle plc
10th Jul 202611:11 amRNS20260709_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
10th Jul 202611:10 amRNS20260709_TATE & LYLE_8.5 EPT RI_UK_MLI
10th Jul 202610:45 amRNSForm 8.3 - Tate & Lyle plc
10th Jul 202610:34 amRNSForm 8.5 (EPT/RI)
9th Jul 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
9th Jul 20263:04 pmRNSForm 8.3 - Tate & Lyle plc
9th Jul 20263:01 pmRNSForm 8.3 TATE & LYLE PLC
9th Jul 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
9th Jul 20262:34 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Public dealing disclosure
9th Jul 20262:12 pmRNSForm 8.3 Tate & Lyle Plc
9th Jul 20262:02 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
9th Jul 20261:06 pmRNSForm 8.3 Tate & Lyle plc
9th Jul 202612:45 pmRNSForm 8.3 - Tate & Lyle PLC
9th Jul 202612:31 pmRNSForm 8.3 Tate & Lyle Plc
9th Jul 202612:07 pmRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
9th Jul 202612:05 pmRNSForm 8.3 - Tate & Lyle plc
9th Jul 202612:00 pmRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
9th Jul 202611:41 amRNSForm 8.5 - TATE & LYLE PLC
9th Jul 202611:37 amRNSForm 8.3 Tate & Lyle Plc
9th Jul 202611:35 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle plc
9th Jul 202611:20 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
9th Jul 202611:19 amRNS20260708_TATE & LYLE_8.5 EPT RI_UK_MLI
9th Jul 202611:01 amRNSForm 8.3 - Tate & Lyle plc
9th Jul 20269:11 amRNSForm 8.5 (EPT/RI)
9th Jul 20268:28 amRNSForm 8.5 (EPT/NON-RI)-Amend-Tate & Lyle PLC
8th Jul 20263:25 pmRNSForm 8.3 - TATE & LYLE PLC
8th Jul 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
8th Jul 20263:09 pmRNSForm 8.3 - Tate & Lyle plc
8th Jul 20263:08 pmRNSForm 8.3 - Tate & Lyle plc - Amendment
8th Jul 20263:05 pmRNSForm 8.3 - Tate & Lyle plc - Amendment
8th Jul 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
8th Jul 20262:46 pmRNSForm 8.3 - Tate & Lyle plc
8th Jul 20262:23 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
8th Jul 20261:41 pmRNSForm 8.3 TATE & LYLE PLC
8th Jul 202612:38 pmRNSForm 8.3 - Tate & Lyle plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.